|
Summary Information: Avadel Pharmaceuticals plc American Depositary Shares NASDAQ:AVDL |
admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Avadel Pharmaceuticals plc is a biopharmaceutical company primarily focused on the development and FDA approval of FT218, an investigational, once-nightly, extended-release formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy.
__The following are links to various summary and news pages for __Avadel Pharmaceuticals plc American Depositary Shares [ AVDL ]. __Note: Some Links might not have information for the company. |
|